Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 9 Prostatic Neoplasms 3 Precancerous Conditions 3 Glioma 3 Astrocytoma 3 Adenomatous Polyposis Coli 3 Skin Neoplasms 2 Sarcoma, Ewing 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive 2 Medulloblastoma 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma, Basal Cell 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Typical Teratoid Rhabdoid Tumor 1 Stomach Neoplasms 1 Rhabdoid Tumor 1 Osteosarcoma Recurrent 1 Oligodendroglioma 1 Non-melanoma Skin Cancer 1 Neoplasms 1 Melanoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Keratosis, Actinic 1 Gastritis, Atrophic 1 Esophageal Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma Recurrent × Eflornithine × Clear all

NCT06892678 2026-05-14

DFMO

Montefiore Medical Center

Phase 1/2 Recruiting

Osteosarcoma Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡